133 related articles for article (PubMed ID: 29635619)
21. Efficacy of antibiotic treatment of implant-associated
Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
[TBL] [Abstract][Full Text] [Related]
22. Characterization and cytocompatibility of an antibiotic/chitosan/cyclodextrins nanocoating on titanium implants.
Mattioli-Belmonte M; Cometa S; Ferretti C; Iatta R; Trapani A; Ceci E; Falconi M; De Giglio E
Carbohydr Polym; 2014 Sep; 110():173-82. PubMed ID: 24906744
[TBL] [Abstract][Full Text] [Related]
23. Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization.
Peterson LR; Quick JN; Jensen B; Homann S; Johnson S; Tenquist J; Shanholtzer C; Petzel RA; Sinn L; Gerding DN
Arch Intern Med; 1990 Oct; 150(10):2151-5. PubMed ID: 2222100
[TBL] [Abstract][Full Text] [Related]
24. Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.
Kiamco MM; Atci E; Mohamed A; Call DR; Beyenal H
Appl Environ Microbiol; 2017 Mar; 83(6):. PubMed ID: 28062458
[TBL] [Abstract][Full Text] [Related]
25. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
26. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
[TBL] [Abstract][Full Text] [Related]
27. New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.
Revest M; Jacqueline C; Boudjemaa R; Caillon J; Le Mabecque V; Breteche A; Steenkeste K; Tattevin P; Potel G; Michelet C; Fontaine-Aupart MP; Boutoille D
J Antimicrob Chemother; 2016 May; 71(5):1291-9. PubMed ID: 26851611
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems.
Cao Z; Sun Y
J Biomed Mater Res A; 2009 Jun; 89(4):960-7. PubMed ID: 18470925
[TBL] [Abstract][Full Text] [Related]
29. Dry powder formulation for pulmonary infections: Ciprofloxacin loaded in chitosan sub-micron particles generated by electrospray.
Arauzo B; Lobera MP; Monzon A; Santamaria J
Carbohydr Polym; 2021 Dec; 273():118543. PubMed ID: 34560955
[TBL] [Abstract][Full Text] [Related]
30. Treatment of experimental osteomyelitis by liposomal antibiotics.
Kadry AA; Al-Suwayeh SA; Abd-Allah AR; Bayomi MA
J Antimicrob Chemother; 2004 Dec; 54(6):1103-8. PubMed ID: 15486079
[TBL] [Abstract][Full Text] [Related]
31. Elution of antibiotics from poly(methyl methacrylate) bone cement after extended implantation does not necessarily clear the infection despite susceptibility of the clinical isolates.
Swearingen MC; Granger JF; Sullivan A; Stoodley P
Pathog Dis; 2016 Feb; 74(1):ftv103. PubMed ID: 26527622
[TBL] [Abstract][Full Text] [Related]
32. Investigation of chitosan's antibacterial activity against vancomycin resistant microorganisms and their biofilms.
Costa EM; Silva S; Veiga M; Vicente S; Tavaria FK; Pintado ME
Carbohydr Polym; 2017 Oct; 174():369-376. PubMed ID: 28821080
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of antibacterial activity and cytocompatibility of ciprofloxacin loaded gelatin-hydroxyapatite scaffolds as a local drug delivery system for osteomyelitis treatment.
Krishnan AG; Jayaram L; Biswas R; Nair M
Tissue Eng Part A; 2015 Apr; 21(7-8):1422-31. PubMed ID: 25567452
[TBL] [Abstract][Full Text] [Related]
34. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
35. Chitosan-Based Film of Tyrothricin for Enhanced Antimicrobial Activity against Common Skin Pathogens Including Staphylococcus aureus.
Han SD; Sung HJ; Lee GH; Jun JH; Son M; Kang MJ
J Microbiol Biotechnol; 2016 May; 26(5):953-8. PubMed ID: 26907760
[TBL] [Abstract][Full Text] [Related]
36. Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials.
Falagas ME; Bliziotis IA; Fragoulis KN
Am J Infect Control; 2007 Mar; 35(2):106-14. PubMed ID: 17327190
[TBL] [Abstract][Full Text] [Related]
37. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
Vitkauskiene A; Sakalauskas R; Dudzevicius V
Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility patterns of Staphylococcus aureus biofilms in diabetic foot infections.
Mottola C; Matias CS; Mendes JJ; Melo-Cristino J; Tavares L; Cavaco-Silva P; Oliveira M
BMC Microbiol; 2016 Jun; 16(1):119. PubMed ID: 27339028
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.
Koort JK; Mäkinen TJ; Suokas E; Veiranto M; Jalava J; Knuuti J; Törmälä P; Aro HT
Antimicrob Agents Chemother; 2005 Apr; 49(4):1502-8. PubMed ID: 15793132
[TBL] [Abstract][Full Text] [Related]
40. Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis.
Torge A; Wagner S; Chaves PS; Oliveira EG; Guterres SS; Pohlmann AR; Titz A; Schneider M; Beck RCR
Int J Pharm; 2017 Jul; 527(1-2):92-102. PubMed ID: 28499793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
